Articles with "access new" as a keyword



Photo from archive.org

Access to new Schiff bases tethered with pyrazolopyrimidinone as antibacterial agents: Design and synthesis, molecular docking and DFT analysis

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Molecular Structure"

DOI: 10.1016/j.molstruc.2021.131523

Abstract: Abstract In the present study, a new series of Schiff bases (4a-h) were designed and synthesized via the treatment of the previously prepared 5-aminopyrazolopyrimidinone 3 with a series of differently substituted arylaldehydes. Compound 3 was… read more here.

Keywords: schiff bases; access new; dft; new schiff ... See more keywords
Photo by vlisidis from unsplash

Easy access to new anthracenyl π-conjugates: generation of distinct AIE-active materials

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of Materials Chemistry C"

DOI: 10.1039/c6tc05671g

Abstract: Inspired by the well-established distyryl anthracenyl (DSA) π-conjugates as aggregation-induced emission active (AIE) materials and the evolution of the synthesis/optoelectronic properties of numerous anthracene-based π-conjugates, a new series of 9-or 10-(hetero)arylated anthracenyl π-conjugates were synthesized… read more here.

Keywords: anthracenyl conjugates; access new; new anthracenyl; easy access ... See more keywords

Accelerated access to new drugs and technologies

Sign Up to like & get
recommendations!
Published in 2017 at "British Medical Journal"

DOI: 10.1136/bmj.j5387

Abstract: UK government’s proposed scheme is unlikely to improve patient outcomes read more here.

Keywords: accelerated access; access new; drugs technologies; new drugs ... See more keywords

Factors Influencing Delays in Patient Access to New Medicines in Canada: A Retrospective Study of Reimbursement Processes in Public Drug Plans

Sign Up to like & get
recommendations!
Published in 2019 at "Frontiers in Pharmacology"

DOI: 10.3389/fphar.2019.00196

Abstract: Individuals who rely on public health payers to access new medicines can access fewer innovative medicines and must wait longer in Canada compared to major markets around the world. New medicines/indications approved by Health Canada… read more here.

Keywords: access new; time; reimbursement; drug ... See more keywords